Esquema de inmunizaciones
DOI:
https://doi.org/10.55204/trc.v9789i8788.23Keywords:
Immunization, Vaccine, Covid-19.Abstract
Through vaccination, the immune system acquires sufficient defenses to stop an infectious disease as long as the scheme is fully and adequately complied with. Vaccines can prevent more than 2.5 million deaths worldwide, being the main health strategy to save lives. In America, it has managed to control and eradicate infectious diseases such as polio, smallpox and measles, which have evolved over the years according to the needs of the population.The vaccines against Covid 19, which are in charge of the first level of care, aim to cover with a higher percentage of coverage, reducing the spread of the virus, the symptoms from severe to mild, avoiding the saturation of the second and third level of health care, and also reducing mortality.As this is a review with a qualitative approach, articles and documents with great investigative value were analyzed, as shown by the WHO and the Ministry of Public Health of Ecuador.
Downloads
References
Arbo Sosa, A., Falleiros-Arlant, L. H., López, E. L., Del Castillo, J. B., De Cuella, C. M., Moreno, G., Rolón, R., Cerda, J., Eguiazú, S., Roger, R. A., De Rolón Ana, C., Dolores, L., Héctor, C., Ida, E., Julio, N., Araya, A., Lidia, G., José, S. M., Mirian, C., ... Ana, A. (2018). Remarks on the possibility of the introduction of fractionated dose of the inactivated poliomyelitis vaccine in the Latin American child immunization schedule. Revista Chilena de Freedman, D., & Leder, K. (2020). Vacunas para viajar.1–32.Izquierdo, G., & Martínez, D. (2020). Vacunas e inmunizaciones en recién nacidos y recién nacidos prematuros. Revista Médica Clínica Las Condes, 31(3), 270–279. https://doi.org/10.1016/j.rmclc.2020.04.004Ministerio de Salud Pública. (2019). Ac_00063_2019 Oct 31.Pdf(p. 104). https://www.salud.gob.ec/catalogo-de-normas-politicas-reglamentos-protocolos-manuales-planes-guias-y-otros-del-msp/Ministerio de Salud Pública del Ecuador. (2021). Lineamiento para el Plan de Vacunación contra la COVID 19. Ministerio de Salud Pública, 1(4), 1–15. https://www.salud.gob.ec/wp-content/uploads/2021/12/Lineamiento-para-vacunación-dosis-de-refuerzo-ultimo-V4_22-12-2021.pdfMSP. (2021a). Lineamiento para el Plan de Vacunación contra COVID-19 en población adolescente de 12-17 años 29 días con Vacuna PfizerBioNTech (Comirnaty). En Ministerio de Salud. https://www.salud.gob.ec/wp-content/uploads/2021/09/Lineamiento-ADOLESCENTES-12-17-A-PFIZER-13-09-2021.pdfMSP. (2021b). Lineamientos de obligatoriedad de la vacunación contra SARS CoV-2 .22. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwi96OPngPL1AhXSQjABHVvVA6YQFnoECAQQAQ&url=https%3A%2F%2Fwww.salud.gob.ec%2Fwp-content%2Fuploads%2F2021%2F12%2FLineamiento-obligatoriedad-vacuna-COVID-19.pdf&usg=AOvVaw2v_kFP2k12600n_OMS. (2017). Implementación del uso de dosis fraccionadas de IPV (fIPV). Oms, 1, 1–13. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=43023&lang=esOPS. (2021). Manual de vigilancia de eventos supuestamente atribuiblesa la vacunación o inmunización en la Región de las Américas.Pírez, C., Peluffo, G., Barrios, P., & Pujadas, M. (2021). Inmunizaciones como estrategia de salud pública. Archivos
Porras, O. (2009). Vacunación: esquemas y recomendaciones generales (Immunization: schedule and general recommendations). Asociación Costarricense de Pediatría, 2(1409–0090), 65–75. https://www.scielo.sa.cr/pdf/apc/v20n2/a02v20n2.pdfRojas, L., Cruz, B., Rojas, L., Rojas, A., Rojas, A., & Villagómez, M. (2022). Análisis del comportamiento epidemiológico del COVID-19 y el efecto de la vacunación sobre el mismo en Ecuador. La Ciencia al Serviciio de la Salud y la Nutrición, Edición Es, 43–58. http://revistas.espoch.edu.ec/index.php/cssn/article/view/648/643Tregnaghi, M., Debbag, R., Falleiros Arlant, L. H., Avila Aguero, M. L., Muñoz, G., Dueñas, L., Aristegui, J., Romero Feregrino, R., Mascareñas de los Santos, A., Castillo, C., Deseda, C., Brea, J., & Pírez, M. C. (2019). Esquemas de vacunación recomendados para la población de 0 a 18 años de edad. Rev Latin Infect Pediatr, 32(4), 133–144.
https://www.medigraphic.com/pdfs/infectologia/lip-2019/lip194b.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Jacinto Eugenio Pérez Ramírez, Tannya Jasmin Rojas Rojas, Karla Alejandra Molina González, Laura Cristina Reyes Coronel
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
